Pharmaceutical companies require enhanced levels of security due to the sensitive data stored on site. There is always a critical need to monitor and control who is entering the building, to prevent the risks associated with unauthorized access. Beyond an access control solution to support the company’s high security requirements, there was a need to control the flow of people entering and exiting the building.

The centre worked closely with Boon Edam to establish potential threats and ensure the appropriate level of security was incorporated into the new entry solution. It was important for the entrance solution to be correct, not only to meet the building’s requirements, but also to fit with the existing culture. After evaluating the range of entry options, the client chose Boon Edam’s automatic Tourlock 180+90 security revolving door with an aluminum finish for its entrance.

“We had worked with Pharm Research Associates on their headquarters in Reading, so we knew the client well and were able to recommend the best solution for their needs,” said Neil Simons, National Sales Manager, Boon Edam Limited UK. “With the facility storing sensitive clinical data, the Tourlock 180+90 was the perfect fit. Not only does it provide a stronger, more technical security solution for the building, it also allows for higher throughput levels.”

The Tourlock 180+90 prevents unauthorised entry attempts (tailgating and piggybacking), while supporting simultaneous, bi-directional throughput – a level of security that precisely matched the client’s needs.

The project took eight months from confirmation to installation, and despite some bad weather, Boon Edam installed the new door in only four days. Boon Edam also provided a complimentary customer orientation, to inform the management and staff how to properly use and care for the door throughout its lifetime.